Clinical Trial Update: Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the combination of anlotinib with trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING